Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1181267-36-6 | MDL No. : | MFCD26960659 |
Formula : | C21H31N3O3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | WLBGIVZZFISEJL-UHFFFAOYSA-N |
M.W : | 373.49 | Pubchem ID : | 54672427 |
Synonyms : |
|
Num. heavy atoms : | 27 |
Num. arom. heavy atoms : | 9 |
Fraction Csp3 : | 0.62 |
Num. rotatable bonds : | 8 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 111.14 |
TPSA : | 56.59 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | Yes |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | Yes |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | Yes |
CYP3A4 inhibitor : | Yes |
Log Kp (skin permeation) : | -6.41 cm/s |
Log Po/w (iLOGP) : | 3.92 |
Log Po/w (XLOGP3) : | 3.05 |
Log Po/w (WLOGP) : | 3.81 |
Log Po/w (MLOGP) : | 2.48 |
Log Po/w (SILICOS-IT) : | 2.99 |
Consensus Log Po/w : | 3.25 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.8 |
Solubility : | 0.0598 mg/ml ; 0.00016 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.9 |
Solubility : | 0.0465 mg/ml ; 0.000125 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -4.76 |
Solubility : | 0.00642 mg/ml ; 0.0000172 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 2.0 |
Synthetic accessibility : | 3.38 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
92% | With sodium carbonate; sodium hydroxide In water at 40℃; for 2 h; Cooling with ice | To the reaction flask was added 38.00 g of 2-chloroethyl ethyl ether (compound 4, 0.35 mol) and 90.4 g of 4- (1H-benzo [d]Imidazol-2-yl) piperidine-1-carboxylate (compound 3, 0.3 mol) (40percent) in water was added 7 mlPolyethylene glycol-400,(0.25 mol NaOH and 0.1 mol Na2CO3) were added slowly under ice-cooling, and the mixture was stirred rapidly at 40C for 2 hours. After completion of the reaction, the reaction solution was cooled, extracted with ether, washed with saturated brine, dried and filtered , The solvent was removed to give 103.1 g of compound 5 in 92percent yield. |
93 g | With sodium iodide; sodium hydroxide In dimethyl sulfoxide at 95 - 100℃; for 3 h; | Example-17: Preparation of tert-butyl 4-(l-(2-ethoxyethyl)-lH-benzo[d]imidazol-2-yl) piperidine-l-carboxylate (Formula-32) Tert-butyl 4-(lH-benzo[d]imidazol-2-yl)piperidine-l-carboxylate compound of formula-31 (100 gm), sodium iodide (10 gm) and l-chloro-2-ethoxyethane (54 gm) were slowly added to a pre-heated mixture of dimethylsulfoxide (200 ml) and sodium hydroxide (39.8 gm) at 40-45°C. Heated the reaction mixture to 95-100°C and stirred for 3 hrs at the same temperature. Cooled the reaction mixture to 10-15°C and water was slowly added. Neutralized the reaction mixture using aqueous hydrochloric acid. Ethyl acetate was added to the reaction mixture and stirred for 20 min. Both the organic and aqueous layers were separated and the organic layer was washed with sodium chloride solution. Distilled off the solvent completely from the organic layer under reduced pressure. Ethyl acetate (50 ml) was added to the obtained compound. Heated the reaction mixture to 60-65°C and stirred for 15 min at the same temperature. Reduced the temperature of the reaction mixture to 40-45°C and petroleum ether (650 ml) was slowly added. Cooled the reaction mixture to 0-5°C and stirred for 10 min at the same temperature. Filtered the precipitated solid, washed with petroleum ether and dried to get the title compound. Yield: 93.0 gm. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
91% | With potassium hydroxide In toluene at 50℃; | Example 11 : Preparation of4-[1 -(2-ethoxyethyl)-1 H-benzoimidazol-2-yl]-piperidine-1 -carboxylic acid tert-butyl ester; In a reaction vessel, 4-(1 H-benzoimidazol-2-yl)-piperidine-1 -carboxylic acid tert-butyl ester(1.5g) prepared in the Example 10, toluene(10ml_) and potassium hydroxide(O.δg) were introduced, and temperature of the mixture was controlled to 500C or more. To the mixture, ethoxyethanol methane sulfonate^ .3g) was added, and then, it was stirred at the same temperature until the reaction was completed. After the reaction was completed, distilled water(IOmL) was added to separate layers, and then an organic layer was condensed to obtain4-[1 -(2-ethoxyethyl)-1 H-benzoimidazol-2-yl]-piperidine-1 -carboxylic acid tert-butyl ester(1.7g, 91 percent).1H-NMR, 400 MHz, CDCI3, ppm : 1.07(t, 3H)1 1.47(s, 9H), 1.92(m, 2H), 2.01 (S, 2H), 2.85(s, 2H), 3.14(m, 1 H), 3.36(m, 2H), 3.69(t, 2H), 4.28(t, 2H), 7.12-7.26(m, 3H), 7.75(t, 1 H) |
91% | Stage #1: With potassium hydroxide In toluene at 50℃; Stage #2: at 50℃; |
Example 11 Preparation of 4-[1-(2-ethoxyethyl)-1H-benzoimidazol-2-yl]-piperidine-1-carboxylic acid tert-butyl ester In a reaction vessel, 4-(1H-benzoimidazol-2-yl)-piperidine-1-carboxylic acid tert-butyl ester (1.5 g) prepared in the Example 10, toluene (10 mL) and potassium hydroxide (0.8 g) were introduced, and temperature of the mixture was controlled to 50° C. or more. To the mixture, ethoxyethanol methane sulfonate (1.3 g) was added, and then, it was stirred at the same temperature until the reaction was completed. After the reaction was completed, distilled water (10 mL) was added to separate layers, and then an organic layer was condensed to obtain 4-[1-(2-ethoxyethyl)-1H-benzoimidazol-2-yl]-piperidine-1-carboxylic acid tert-butyl ester (1.7 g, 91percent). 1H-NMR, 400 MHz, CDCl3, ppm: 1.07 (t, 3H), 1.47 (s, 9H), 1.92 (m, 2H), 2.01 (s, 2H), 2.85 (s, 2H), 3.14 (m, 1H), 3.36 (m, 2H), 3.69 (t, 2H), 4.28 (t, 2H), 7.12-7.26 (m, 3H), 7.75 (t, 1H) |
[ 1841081-72-8 ]
1-(2-Ethoxyethyl)-2-(piperidin-4-yl)-1H-benzo[d]imidazole hydrochloride
Similarity: 0.78
[ 40608-76-2 ]
2-Benzyl-5-methoxy-1H-benzo[d]imidazole
Similarity: 0.60
[ 1229000-10-5 ]
tert-Butyl 3-(1H-benzo[d]imidazol-2-yl)piperidine-1-carboxylate
Similarity: 0.84
[ 132873-77-9 ]
tert-Butyl 4-(bromomethyl)-1H-benzo[d]imidazole-1-carboxylate
Similarity: 0.68
[ 214147-60-1 ]
tert-Butyl 2-chloro-1H-benzo[d]imidazole-1-carboxylate
Similarity: 0.67
[ 1229000-10-5 ]
tert-Butyl 3-(1H-benzo[d]imidazol-2-yl)piperidine-1-carboxylate
Similarity: 0.84
[ 1841081-72-8 ]
1-(2-Ethoxyethyl)-2-(piperidin-4-yl)-1H-benzo[d]imidazole hydrochloride
Similarity: 0.78
[ 38385-95-4 ]
2-(Piperidin-4-yl)-1H-benzo[d]imidazole
Similarity: 0.65
[ 167484-91-5 ]
tert-Butyl 5-fluorospiro[indoline-3,4'-piperidine]-1'-carboxylate
Similarity: 0.62
[ 125541-22-2 ]
tert-Butyl 4-(phenylamino)piperidine-1-carboxylate
Similarity: 0.60
[ 1229000-10-5 ]
tert-Butyl 3-(1H-benzo[d]imidazol-2-yl)piperidine-1-carboxylate
Similarity: 0.84
[ 1841081-72-8 ]
1-(2-Ethoxyethyl)-2-(piperidin-4-yl)-1H-benzo[d]imidazole hydrochloride
Similarity: 0.78
[ 3543-74-6 ]
Ethyl 4-(5-(bis(2-hydroxyethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoate
Similarity: 0.71
[ 3543-73-5 ]
Ethyl 4-(5-amino-1-methyl-1H-benzo[d]imidazol-2-yl)butanoate
Similarity: 0.69
[ 132873-77-9 ]
tert-Butyl 4-(bromomethyl)-1H-benzo[d]imidazole-1-carboxylate
Similarity: 0.68